CLL Forum Video Updates For Patients

The Big Conversation: How to Optimise Patient Outcomes Through Better Communications

Dr Renata Walewska, Dr Lina Eliasson and Zack Pemberton-Whiteley have The Big Conversation: How to Optimise Patient Outcomes Through Better Communications

www.big-conversation.co.uk

 

Coronavirus and chronic lymphocytic leukaemia (CLL)

Dr Piers Patten, of Kings College London and Marc Auckland, Chair of Trustees at CLL Support and CLL patient discuss Covid-19 and CLL.

View player: https://youtu.be/nxAkCi_v7ss

 

Coronavirus and chronic lymphocytic leukaemia (CLL)

Professor Chris Fegan from the University Hospital of Wales discusses the impact of coronavirus on patients with CLL.

View player: https://youtu.be/-kuS2vJIqI0

 

Edinburgh international Workshop on CLL (iwCLL), 20th September 2019.

UK CLL Forum Clinical Sciences Day collaboration with CLL Advocates Network in Edinburgh.  State of the art CLL medicine, for an international shared plenary of CLL patients, patient groups and the clinical communities.

‘CLL in the UK and beyond in 2019’ –  Prof Anna Schuh of the University of Oxford discusses optimal therapy for CLL in 2019 and can we achieve this in the UK?

View player: https://youtu.be/c0DqxHb8HWQ

 

‘CLL in the UK and beyond in 2019’ –  Prof Chris Fegan (UK) University Hospital of Wales discusses current gaps in knowledge and care – The ‘Known Unknowns’ and The ‘Unknown Unknowns’

View player: https://youtu.be/B_kzUM-SHQU

 

Orlando, Florida American Society of Haematology (ASH), 7-10 December 2019

UK CLL Forum video updates on advances in the treatment of CLL, created  for UK patients.

Professor Pete Hillmen talks about what chronic lymphocytic leukaemia (CLL) topics were discussed at the pioneering conference.

View player: https://youtu.be/HRnlQvHrgA0

 

Professor John Gribben provides an update on the hot topics in CLL from ASH 2019.

View player: https://youtu.be/Qs2qG3Uv0Mw

 

Dr George Follows describes how the ELEVATE clinical trial, presented at ASH, shows that acalabrutinib is an effective treatment option for chronic lymphocytic leukaemia (CLL) patients, and explains his hopes for its future use in the UK.

View player: https://youtu.be/8ss7J1VMCIQ

 

Dr Renata Walewska talks about advances in chronic lymphocytic leukaemia (CLL) treatment.

View player: https://youtu.be/PrxeGl9GPe8

 

Dr Renata Walewska describes clinical trial data presented at ASH 2019, including an update on the MURANO trial in chronic lymphocytic leukaemia (CLL).

View player: https://youtu.be/_bQ6T9oltro